✦ LIBER ✦

Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity

✍ Scribed by Eithan Galun; Norah A. Terrault; Rachel Eren; Arie Zauberman; Ofer Nussbaum; Dov Terkieltaub; Meirav Zohar; Rachel Buchnik; Zvi Ackerman; Rifaat Safadi; Yaffa Ashur; Sara Misrachi; Yael Liberman; Ludmila Rivkin; Shlomo Dagan

Book ID: 116651204
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 231 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2006.08.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical evaluation (phase I) of a combi

Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties

✍ Eithan Galun; Rachel Eren; Rifaat Safadi; Yaffa Ashour; Norah Terrault; Emmet B. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

First administration to humans of a mono

First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity

✍ A.B.H. Bakker; C. Python; C.J. Kissling; P. Pandya; W.E. Marissen; M.F. Brink; F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Hepatic immunohistochemical staining wit

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection

✍ Chris Verslype; Frederik Nevens; Nicoletta Sinelli; Carine Clarysse; Jacques Pir 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 323 KB

281 SAFETY AND PHARMACOKINETICS OF A NOV

281 SAFETY AND PHARMACOKINETICS OF A NOVEL HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST THE E2 GLYCOPROTEIN OF HEPATITIS C VIRUS (MBL-HCV1) IN HEALTHY VOLUNTEERS

✍ B.A. Leav; S. Sloan; B.M. Blair; P. Cheslock; M. Knauber; D.M. Ambrosino; D.C. M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Production of monoclonal antibodies agai

Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system

✍ Masaharu Takahashi; Yu Hoshino; Toshinori Tanaka; Hideyuki Takahashi; Tsutomu Ni 📂 Article 📅 2008 🏛 Springer Vienna 🌐 English ⚖ 541 KB

Safety profile and clinical activity of

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

✍ Merrill, J. T.; Wallace, D. J.; Petri, M.; Kirou, K. A.; Yao, Y.; White, W. I.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 385 KB